Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial

BMJ (Online)

Volumn 354, Issue , 2016, Pages

  Guthrie, Bruce ^a   Kavanagh, Kimberley ^b   Robertson, Chris ^b   Barnett, Karen ^c   Treweek, Shaun ^d   Petrie, Dennis ^e   Ritchie, Lewis ^f   Bennie, Marion ^b,g  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g INFORMATION SERVICES DIVISION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; BEHAVIOR CHANGE; CLINICAL PRACTICE; CLUSTER ANALYSIS; CONTROLLED STUDY; DRUG USE; E-MAIL; FEEDBACK SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MULTICENTER STUDY; ODDS RATIO; PATIENT EDUCATION; PATIENT SAFETY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCOTLAND; SECONDARY ANALYSIS; CLINICAL TRIAL; METHODOLOGY; PRIMARY HEALTH CARE; STANDARDS; TOTAL QUALITY MANAGEMENT;

DRUG PRESCRIPTIONS; FEEDBACK; HUMANS; PATIENT SAFETY; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; QUALITY IMPROVEMENT; RESEARCH DESIGN; SCOTLAND;

EID: 84984697928     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i4079     Document Type: Article

References (40)

1. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329:15-9. doi:10.1136/bmj.329.7456.15
2. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-64. doi:10.1056/ NEJMsa020703
3. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289:1107-16. doi:10.1001/jama.289.9.1107
4. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47. doi:10.1111/j.1365-2125.2006.02698.x
5. Banerjee S. The use of antipsychotic medication for people with dementia: time for action.Department of Health, 2009
6. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31. doi:10.1111/j.1532-5415.2012.03923.x
7. OMahony D, Gallagher P, Ryan C, et al. STOPP & START criteria: A new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med 2010;1:45-51doi:10.1016/j.eurger.2010.01.007
8. Dreischulte T, Grant AM, McCowan C, McAnaw JJ, Guthrie B. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol 2012;12:5. doi:10.1186/1472-6904-12-5
9. Spencer R, Bell B, Avery AJ, Gookey G, Campbell SM. Royal College of General Practitioners. Identification of an updated set of prescribing- safety indicators for GPs. Br J Gen Pract 2014;64:e181-90. doi:10.3399/bjgp14X677806
10. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011;342:d3514. doi:10.1136/bmj.d3514
11. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006;15:23-31. doi:10.1136/qshc.2004.012153
12. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol 2008;65:303-16. doi:10.1111/j.1365-2125.2007.03071.x
13. Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012;379:1310-9. doi:10.1016/S0140-6736(11)61817-5
14. Dreischulte T, Donnan P, Grant A, Hapca A, McCowan C, Guthrie B. Safer Prescribing-A Trial of Education, Informatics, and Financial Incentives. N Engl J Med 2016;374:1053-64. doi:10.1056/NEJMsa1508955
15. Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012;6:CD000259
16. Holm M. Intervention against long-term use of hypnotics/sedatives in general practice. Scand J Prim Health Care 1990;8:113-7. doi:10.3109/02813439008994941
17. Pimlott NJG, Hux JE, Wilson LM, Kahan M, Li C, Rosser WW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ 2003;168:835-9
18. Curtis JR, Olivieri J, Allison JJ, et al. A group randomized trial to improve safe use of nonsteroidal anti-inflammatory drugs. Am J Manag Care 2005;11:537-43
19. Guthrie B, Treweek S, Petrie D, et al. Protocol for the Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) study: a cluster randomised controlled trial using ePrescribing data. BMJ Open 2012;2:e002359. doi:10.1136/bmjopen-2012-002359
20. Barnett KN, Bennie M, Treweek S, et al. Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) a pragmatic three-arm cluster randomised trial: designing the intervention (ClinicalTrials.gov registration NCT01602705). Implement Sci 2014;9:133. doi: 10.1186/ s13012-014-0133-9
21. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179-211doi:10.1016/0749-5978(91)90020-T
22. Schwarzer R. Self-efficacy in the adoption and maintenance of health behaviors: theoretical approaches and a new model. In: Schwarzer R, ed. Self-efficacy: thought control of action.Hemisphere, 1992: 217-42
23. Avery AJ, Dex GM, Mulvaney C, et al. Development of prescribingsafety indicators for GPs using the RAND Appropriateness Method. Br J Gen Pract 2011;61:e526-36. doi:10.3399/bjgp11X588501
24. Guthrie B, Clark SA, Reynish EL, McCowan C, Morales DR. Differential impact of two risk communications on antipsychotic prescribing to people with dementia in Scotland: segmented regression time series analysis 2001-2011. PLoS One 2013;8:e68976. doi:10.1371/journal. pone.0068976
25. Dreischulte T, Grant A, Donnan P, et al. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: the DQIP study protocol. Implement Sci 2012;7:24. doi:10.1186/1748-5908-7-24
26. Donnar A, Klar N. Design and analysis of cluster randomization trials in health research.Arnold, 2000
27. Rotondi M. CRTSize: sample size estimation functions for cluster randomized trials. 2011. http://cran.r-project.org/web/packages/ CRTSize/index.html
28. Grudniewicz A, Kealy R, Rodseth RN, Hamid J, Rudoler D, Straus SE. What is the effectiveness of printed educational materials on primary care physician knowledge, behaviour, and patient outcomes: a systematic review and meta-analyses. Implement Sci 2015;10:164. doi:10.1186/s13012-015-0347-5
29. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655. doi:10.1136/bmj.a1655
30. Ballard C, Hanney ML, Theodoulou M, et al. DART-AD investigators. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009;8:151-7. doi:10.1016/S1474-4422(08)70295-3
31. Ballard C, Lana MM, Theodoulou M, et al. Investigators DART AD. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med 2008;5:e76. doi:10.1371/journal.pmed.0050076
32. Hallsworth M, Chadborn T, Sallis A, et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 2016;387:1743-52. doi:10.1016/S0140-6736(16)00215-4
33. Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev 2009;3:CD001096
34. Peterson JF, Rosenbaum BP, Waitman LR, et al. Physicians response to guided geriatric dosing: initial results from a randomized trial. Stud Health Technol Inform 2007;129:1037-40
35. Judge J, Field TS, DeFlorio M, et al. Prescribers responses to alerts during medication ordering in the long term care setting. J Am Med Inform Assoc 2006;13:385-90. doi:10.1197/jamia.M1945
36. Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ 2003;169:549-56
37. de Groot DA, de Vries M, Joling KJ, et al. Specifying ICD9, ICPC and ATC codes for the STOPP/START criteria: a multidisciplinary consensus panel. Age Ageing 2014;43:773-8. doi:10.1093/ageing/ afu075
38. Hui Chen L, Hedegaard H, Warner M. Drug-poisoning deaths involving opioid analgesics. National Centre for Health Statistics, 2014: 1999-2011
39. Ruscitto A, Smith BH, Guthrie B. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland. Eur J Pain 2015;19:59-66. doi:10.1002/ejp.520
40. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309. doi:10.1046/j.1365-2710.2002.00430.x